Exosomes Derived From Mesenchymal Stem Cells Pretreated With Ischemic Rat Heart Extracts Promote Angiogenesis via the Delivery of DMBT1

Mesenchymal stem cell–derived exosomes (MSC-Exos) have been shown to promote angiogenesis. Treating MSCs with ischemic rat brain extracts was sufficient to augment their benefits in stroke. However, no similar analyses of ischemic heart extracts have been performed to date. We aim to determine whether MSC-Exos derived from MSCs pretreated with ischemic rat heart extract were able to promote angiogenesis and to clarify underlying mechanisms. ELISA (enzyme-linked immunosorbent assay) of heart extracts revealed a significant increase of vascular endothelial growth factor (VEGF) at 24 h post-MI (myocardial infarction) modeling, and time-dependent decreases in hypoxia inducible factor–1α (HIF-1α). MTT and wound healing assays revealed human umbilical vein endothelial cells (HUVECs) migration and proliferation increased following MSCE-Exo treatment (exosomes derived from MSC pretreated with ischemic heart extracts of 24 h post-MI) relative to MSCN-Exo treatment (exosomes derived from MSC pretreated with normal heart extracts). Proteomic analyses of MSCE-Exo and MSCN-Exo were conducted to screen for cargo proteins promoting angiogenesis. Result revealed several angiogenesis-related proteins were upregulated in MSCE-Exo, including DMBT1 (deleted in malignant brain tumors 1). When DMBT1 was silenced in MSCs, HUVECs with MSCDMBT1 RNAi-Exo treatment exhibited impaired proliferative and migratory activity and reductions of DMBT1, p-Akt, β-catenin, and VEGF. To explore how ischemic heart extracts took effects, ELISA was conducted showing a significant increase of IL-22 at 24 h post-MI modeling. P-STAT3, IL22RA1, DMBT1, and VEGF proteins were increased in MSCE relative to MSCN, and VEGF and DMBT1 were increased in MSCE-Exos. Together, these suggest that IL-22 upregulation in ischemic heart extracts can increase DMBT1 in MSCs. Exosomes derived from those MSCs deliver DMBT1 to HUVECs, thereby enhancing their migratory and proliferative activity.

• Publication year

  2022

• Venue

  Cell Transplantation

• Publication date

  2022-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/09636897221102898PMID 35726847PMCID 9218457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system.

  2021cited by this paper
• in in Humans.

  2021cited by this paper
• XQ-1H promotes cerebral angiogenesis via activating PI3K/Akt/GSK3β/β-catenin/VEGF signal in mice exposed to cerebral ischemic injury.

  2021cited by this paper
• Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations

  2021cited by this paper
• The Role of Interleukins in Colorectal Cancer

  2020cited by this paper
• Angiogenesis-Related Functions of Wnt Signaling in Colorectal Carcinogenesis

  2020cited by this paper
• Toward the Clinical Application of Therapeutic Angiogenesis Against Pediatric Ischemic Retinopathy

  2020cited by this paper
• IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling

  2019cited by this paper
• Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases

  2019cited by this paper
• The microRNA regulatory landscape of MSC-derived exosomes: a systems view

  2018cited by this paper
• Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury

  2018cited by this paper
• Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis

  2018cited by this paper
• Approaches to therapeutic angiogenesis for ischemic heart disease

  2018cited by this paper
• Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis

  2017cited by this paper
• Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR‐mediated VEGF production

  2017cited by this paper
• MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction

  2017cited by this paper
• Mucosal fluid glycoprotein DMBT1 suppresses twitching motility and virulence of the opportunistic pathogen Pseudomonas aeruginosa

  2017cited by this paper
• Exosomes Mediate Epithelium-Mesenchyme Crosstalk in Organ Development.

  2017cited by this paper
• γδ T Cells Contribute to Injury in the Developing Brain

  2017cited by this paper
• tRNA-Derived Small Non-Coding RNAs in Response to Ischemia Inhibit Angiogenesis

  2016cited by this paper
• Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

  2016cited by this paper
• Communication by Extracellular Vesicles: Where We Are and Where We Need to Go.

  2016cited by this paper
• Microvesicles from brain-extract—treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke

  2016cited by this paper
• Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN

  2016cited by this paper
• The Exosome ‐ A Naturally Secreted Nanoparticle and its Application to Wound Healing

  2016cited by this paper
• Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway

  2016cited by this paper
• Overexpression of Cardiomyocyte Alpha1A-Adrenergic Receptors Attenuates Post-Infarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling

  2016cited by this paper
• Vascular Signal Transducer and Activator of Transcription-3 Promotes Angiogenesis and Neuroplasticity Long-Term After Stroke

  2015cited by this paper
• Overexpression of Cardiomyocyte &agr;1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling

  2015cited by this paper
• Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells

  2015cited by this paper
• Exosomes Secreted from CXCR4 Overexpressing Mesenchymal Stem Cells Promote Cardioprotection via Akt Signaling Pathway following Myocardial Infarction

  2015cited by this paper
• Th22 cell accumulation is associated with colorectal cancer development.

  2015cited by this paper
• Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation

  2015cited by this paper
• Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.

  2015cited by this paper
• Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes.

  2015cited by this paper
• Exosomes/miRNAs as mediating cell-based therapy of stroke

  2014cited by this paper
• Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.

  2014cited by this paper
• Extracellular Vesicles: Potential Roles in Regenerative Medicine

  2014cited by this paper
• Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone

  2014cited by this paper
• Angiogenesis in the Infarcted Myocardium

  2013cited by this paper
• Mesenchymal Stem Cell Transplantation Attenuates Brain Injury After Neonatal Stroke

  2013cited by this paper
• Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model

  2013cited by this paper
• Exosome‐Mediated Transfer of miR‐133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth

  2012cited by this paper
• Impaired Wound Healing in Hypoxic Renal Tubular Cells: Roles of Hypoxia-Inducible Factor-1 and Glycogen Synthase Kinase 3β/β-Catenin Signaling

  2012cited by this paper
• Deleted in Malignant Brain Tumors 1 is Present in the Vascular Extracellular Matrix and Promotes Angiogenesis

  2012cited by this paper
• Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases.

  2012cited by this paper
• DMBT1 is a novel gene induced by IL‐22 in ulcerative colitis

  2011cited by this paper
• Terminal differentiation in epithelia: the role of integrins in hensin polymerization.

  2011cited by this paper
• Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction.

  2011cited by this paper
• Functional microRNA is transferred between glioma cells.

  2010cited by this paper
• A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke

  2010cited by this paper
• Functional delivery of viral miRNAs via exosomes

  2010cited by this paper
• Exosomes: Fit to deliver small RNA.

  2010cited by this paper
• Hypoxia inducible factor 1 (HIF-1) and cardioprotection

  2010cited by this paper
• Imaging myocardial angiogenesis

  2009cited by this paper
• Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine

  2009cited by this paper
• Prospects for stem cell-based therapy.

  2008cited by this paper
• In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function.

  2007cited by this paper
• Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer

  2007cited by this paper
• DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.

  2007cited by this paper
• Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling

  2006cited by this paper
• Expression of pro-Muclin in pancreatic AR42J cells induces functional regulated secretory granules.

  2005cited by this paper
• HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas

  2005cited by this paper
• beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.

  2003cited by this paper
• Angiogenesis in chronically ischaemic human heart following percutaneous myocardial revascularisation

  2002cited by this paper
• Ischemic rat brain extracts induce human marrow stromal cell growth factor production

  2002cited by this paper
• Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10-Related T Cell-Derived Inducible Factor/IL-22

  2001cited by this paper
• Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation

  1999cited by this paper
• A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans.

  1997cited by this paper
• The FASEB Journal express article 10.1096/fj.04-3099fje. Published online May 26, 2005. ©2005 FASEB

  year unknowncited by this paper

• Proangiogenic Mechanisms and Modifications of Mesenchymal Stem Cells with a Focus on Neurological Disorders

  2026cites this paper
• Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia

  2025cites this paper
• Exosome: an overview on enhanced biogenesis by small molecules

  2025cites this paper
• Harnessing the potential of mesenchymal stem cells–derived exosomes in degenerative diseases

  2024cites this paper
• Effect of mesenchymal stem cell-derived exosomes on the inflammatory response after stroke

  2024cites this paper
• Recent Progress in Mesenchymal Stem Cell-Derived Exosomes for Skin Wound Repair

  2024cites this paper
• Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders.

  2024cites this paper
• Exosomes: A new perspective for radiation combined injury as biomarker and therapeutics.

  2024cites this paper
• Engineering of Cell Derived-Nanovesicle as an Alternative to Exosome Therapy

  2023cites this paper
• Mesenchymal stem cell-derived extracellular vesicles/exosome: A promising therapeutic strategy for intracerebral hemorrhage

  2023cites this paper
• Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target

  2023cites this paper
• Harnessing the therapeutic potential of mesenchymal stem cell-derived exosomes in cardiac arrest: Current advances and future perspectives.

  2023cites this paper
• Tumor Necrosis Factor Alpha Preconditioned Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Enhance the Inhibition of Necroptosis of Acinar cells in Severe Acute Pancreatitis

  2023cites this paper
• Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction

  2023cites this paper
• Mesenchymal stem cell‐derived exosomes in myocardial infarction: Therapeutic potential and application

  2023cites this paper
• Cardiac Uptake of Mesenchymal Stem Cell-Derived Extracellular Vesicles after Intramyocardial or Intravenous Injection in Murine Myocardial Infarction

  2022cites this paper
• Visualization of cardiac uptake of bone marrow mesenchymal stem cell‐derived extracellular vesicles after intramyocardial or intravenous injection in murine myocardial infarction

  2022cites this paper
• Effects and Mechanisms of Exosomes from Different Sources in Cerebral Ischemia

  2022cites this paper
• World Journal of Stem Cells

  year unknowncites this paper
• World Journal of Stem Cells

  year unknowncites this paper